Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Preventive Healthcare Services01:30

Preventive Healthcare Services

1.0K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.0K
Primary Healthcare Services01:30

Primary Healthcare Services

1.4K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.4K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

448
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
448
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

12.6K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
12.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Patient-Centered, Culturally Responsive Behavioral Economics Intervention to Optimize Retention in HIV Care.

The American journal of tropical medicine and hygiene·2026
Same author

Improving Postpartum Mental Health and Healthy Lifestyle Behaviors in Women of Color Who Are Pregnant and Experiencing Depression, Anxiety, and Stress Through Group Prenatal Care: A Randomized Controlled Trial.

Journal of midwifery & women's health·2026
Same author

Adding a parent-focused child sexual abuse prevention module to home visiting: a provider cohort study protocol.

Frontiers in public health·2026
Same author

Validation of self‑harm prediction models among formerly incarcerated individuals using health data.

Health & justice·2026
Same author

Predicting and differentiating accidental and self-harm drug poisonings using health records data.

PLOS mental health·2026
Same author

Implementation of Statewide Opioid Prescribing Guidelines in Spine Surgery: A MSSIC Study.

Neurosurgery·2026

相关实验视频

Updated: Jun 24, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.5K

在初级保健中增加暴露前预防 (PrEP):使用多阶段优化战略 (MOST) 框架进行多层次干预的研究方案.

Elizabeth Lockhart1, DeAnne Turner2, Kate Guastaferro3

  • 1Center for Health Policy and Health Services Research, Henry Ford Health, 1 Ford Pl., Detroit, MI 48202, USA.

Contemporary clinical trials
|June 7, 2024
PubMed
概括
此摘要是机器生成的。

这项研究使用多相优化策略 (MOST) 开发了一种多层次干预措施,以增加初级保健提供者的暴露前预防 (PrEP) 处方. 目标是改善优先人口的艾滋病毒预防.

关键词:
基于计算机的模拟.艾滋病病毒 艾滋病病毒 艾滋病病毒实施科学 实施科学多层次的多层次的多相优化策略的多相优化策略.这就是为什么PrEP是PrEP.主要的护理是初级保健.

更多相关视频

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

11.8K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K

相关实验视频

Last Updated: Jun 24, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.5K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

11.8K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K

科学领域:

  • 公共卫生 公共卫生
  • 艾滋病毒预防研究 预防研究
  • 干预科学 干预科学

背景情况:

  • 美国有超过120万人感染艾滋病毒,不成比例地影响关键人群.
  • 暴露前预防 (PrEP) 是一种非常有效的艾滋病毒预防工具.
  • 障碍阻碍了初级保健提供者 (PCP) 的PrEP处方和患者启动.

研究的目的:

  • 确定和优化多层次干预措施,以增加PrEP在初级保健机构的使用率.
  • 解决PCP和患者在PREP方面面临的障碍.
  • 专注于对PrEP启动的优先人群.

主要方法:

  • 使用多相优化策略 (MOST) 框架.
  • 整合了患者和提供者反,以定制干预组件.
  • 采用2^4的因数设计实验来测试干预组件.
  • 包括提供者培训,最佳实践警报,教育视频和风险评估.
  • 质量检查了促进者和实施障碍.

主要成果:

  • 本协议概述了一项在医疗保健中进行的多层次MOST优化试验.
  • 干预组件针对大型医疗保健系统中的提供者和患者.
  • 该研究位于艾滋病毒结束流行病优先管辖区.

结论:

  • 这种多层次干预旨在显著影响艾滋病毒预防.
  • 成功实施可能会导致在医疗保健系统中更广泛的传播.
  • 这代表了医疗保健环境中第一个多层次MOST试验之一.